About Saladax
Saladax is a company based in Bethlehem (United States) founded in 2004 by Salvatore J Salamone.. Saladax has raised $46.32 million across 6 funding rounds from investors including Fosun Pharmaceutical, GE Capital and Ben Franklin Technology Partners. Saladax offers products and services including 5-Fluorouracil Assay and Clozapine Assay. Saladax operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others.
- Headquarter Bethlehem, United States
- Founders Salvatore J Salamone
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Saladax Biomedical, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$46.32 M (USD)
in 6 rounds
-
Latest Funding Round
$22.93 M (USD), Series D
Sep 05, 2013
-
Investors
Fosun Pharmaceutical
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Saladax
Saladax offers a comprehensive portfolio of products and services, including 5-Fluorouracil Assay and Clozapine Assay. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Monitors chemotherapy drug levels for optimal patient dosing
Assesses psychiatric medication levels to ensure effective treatment
Unlock access to complete
Unlock access to complete
Funding Insights of Saladax
Saladax has successfully raised a total of $46.32M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $22.93 million completed in September 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series D — $22.9M
-
First Round
First Round
(01 Nov 2007)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2013 | Amount | Series D - Saladax | Valuation |
investors |
|
| Jun, 2011 | Amount | Debt – Conventional - Saladax | Valuation |
investors |
|
| Mar, 2010 | Amount | Series C - Saladax | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Saladax
Saladax has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Fosun Pharmaceutical, GE Capital and Ben Franklin Technology Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life-Sciences focused VC Firm investing in the US
|
Founded Year | Domain | Location | |
|
Investment and support are provided for Pennsylvania's tech-based companies.
|
Founded Year | Domain | Location | |
|
Early to late stage VC firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Saladax
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Saladax
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Saladax Comparisons
Competitors of Saladax
Saladax operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Unity Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
|
| domain | founded_year | HQ Location |
Genomic sequencing and diagnosis software is provided for healthcare.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Saladax
Frequently Asked Questions about Saladax
When was Saladax founded?
Saladax was founded in 2004 and raised its 1st funding round 3 years after it was founded.
Where is Saladax located?
Saladax is headquartered in Bethlehem, United States.
Who is the current CEO of Saladax?
Salvatore J Salamone is the current CEO of Saladax. They have also founded this company.
Is Saladax a funded company?
Saladax is a funded company, having raised a total of $46.32M across 6 funding rounds to date. The company's 1st funding round was a Series C of $8.4M, raised on Nov 01, 2007.
What does Saladax do?
Founded in 2004 and based in Bethlehem, United States, Saladax Biomedical operates in the oncology sector. MyCare diagnostic blood tests are developed and offered to enable individualized chemotherapy dosing for patients. This approach is intended to enhance treatment outcomes while minimizing toxic side effects. Companion diagnostics are co-developed with pharmaceutical companies to support drug efficacy in clinical development.
Who are the top competitors of Saladax?
Saladax's top competitors include Juno Therapeutics, Personalis and Poseida Therapeutics.
What products or services does Saladax offer?
Saladax offers 5-Fluorouracil Assay and Clozapine Assay.
Who are Saladax's investors?
Saladax has 6 investors. Key investors include Fosun Pharmaceutical, GE Capital, Ben Franklin Technology Partners, Golden Seeds, and Excel Venture Management.